Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells. [electronic resource]
Producer: 20180223Description: 232 p. digitalISSN:- 1471-2407
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.